Delivery Order SPE2DB22D3010-SPE2DB25FP0RV
Award Date
10/15/24
Potential Completion Date
10/16/24
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,422.79 firm-fixed-price delivery order is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a prescription medication. The contract has an ultimate completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $21,965.85 firm-fixed-price delivery order is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a prescription medication, to support federal healthcare programs. The contract has an ultimate completion date of August 27, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal contracts and indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a $1,741.62 firm fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4564605282 OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical product to the government. This delivery order contract is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,348.68 firm fixed-price delivery order contract is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
The Defense Logistics Agency (DLA) awarded a $7,298.44 firm fixed price delivery order to Amerisourcebergen Drug Corp's Corporate Office division for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical products. This order falls under a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. As a major...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,991.18 firm fixed-price delivery order is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, with an ultimate completion date of October 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
This federal contract award is a delivery order issued to AmerisourceBergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA) valued at $5,959.91. The award is for the procurement of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product. The contract does not have a set-aside designation and has a period of performance through August 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, has multiple indefinite delivery contracts (IDCs) with various...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product, with a ceiling value of $4,166.41 and a period of performance through August 2, 2024. The contract is a firm fixed-price arrangement and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and...
This federal contract award to Amerisourcebergen Drug Corporation (Amerisourcebergen) by the Defense Logistics Agency (DLA) is for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a specialty pharmaceutical medication. The $28,723.51 firm fixed price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,015.14 firm fixed-price delivery order is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a medication used for diabetes management. The contract has an ultimate completion date of May 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...